This study aims to assess the knowledge and utilization of cannabis for Amyotrophic Lateral Sclerosis (ALS) treatment among 100 individuals diagnosed with the condition. All persons living with ALS (pALS) are encouraged to participate, regardless of their prior experience with cannabis use. The survey is designed to be anonymous, ensuring the privacy and confidentiality of all respondents. The goal is to gather valuable insights into the perspectives and practices surrounding cannabis use within the ALS community.